Porter, Laura S. http://orcid.org/0000-0002-2962-2378
Carson, James W.
Olsen, Maren
Carson, Kimberly M.
Sanders, Linda
Jones, Lee
Westbrook, Kelly
Keefe, Francis J.
Funding for this research was provided by:
National Center for Complementary and Integrative Health (R01 AT007572)
Article History
Received: 4 September 2018
Accepted: 18 February 2019
First Online: 15 March 2019
Compliance with ethical standards
: All study procedures were approved by the Duke Medical Center Institutional Review Board (IRB). Informed consent was obtained from all individual participants included in the study. Participants were recruited between May, 2014, and January, 2018, from the Duke breast oncology clinic. Contact with potential participants was initiated by each patient’s oncologist via an IRB-approved introductory letter. Individuals who did not refuse further contact were called by study staff who explained the study, answered questions, and verified eligibility. If the patient was eligible and chose to participate, arrangements were made to obtain written consent and administer the baseline assessment. Each participant was paid $190 for full study participation.
: The work of Drs. Porter, Carson, Olsen, Keefe, Westbrook, Ms. Carson, and Ms. Sanders on this study was supported by a grant from the National Institutes of Health. Dr. Jones owns stock in Pacylex, Inc.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.